Figure 1.

Rate of inhibition at 1 times the 50% inhibitory concentration (IC₅₀) for drugs currently used to treat primary amoebic meningoencephalitis (A), Food and Drug Administration–approved compounds identified through the St. Jude Children’s Research Hospital library screen (B), and known antifungals (C). Data are from a single experiment with 4 replicates but are representative of independent biological repeats (n = 3). RLU, relative luminescence unit.